Elicio Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Elicio Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2022 to Q1 2024.
  • Elicio Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $36K, a 89.5% decline year-over-year.
  • Elicio Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $753K.
  • Elicio Therapeutics, Inc. annual Interest Expense for 2023 was $1.06M, a 70.6% decline from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $753K $36K -$306K -89.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.06M -$997K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $1M -$78K -7.24% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $714K -$353K -33.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $342K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $1.08M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $1.07M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.